BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Pharmova Ltd: key numbers
- Share price
- ₹935.05
- Market cap
- ₹14,894 Cr
- Revenue (annual)
- ₹8,280 Cr
- Net profit (annual)
- ₹398.5 Cr
- P/E (TTM)
- 56.6×Sector 49.0×
- Promoter holding
- 47.68%+0.00% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Pharmova Ltd
All →Jubilant Pharmova Annual General Meeting
Jubilant Pharmova shareholders passed a special resolution approving private placement of Non-Convertible Debentures via postal ballot. Voting results show 99.39% in favour of the NCD issuance.
Jubilant Pharmova Earnings Call Transcript: Key Takeaways
Revenue rose 21% YoY to ₹2,370 Cr, but PAT was only ₹31 Cr as margins fell on Montreal losses (>₹80 Cr in Q2). Management guides H2 mid-teen margins and deferred FY28 guidance.
Jubilant Pharmova Employee Stock Options
Jubilant Pharmova approved a grant of 1,907 RSUs to eligible employees under its 2018 ESOP plan. No monetary event value is disclosed.
- Execution
- Vesting over 3 years from the date of grant; exercisable within 1 year of vesting
Jubilant Pharmova Results Update
Q2 revenue rose 21% to Rs 2,370 Cr, but EBITDA fell 27% and PAT dropped to Rs 31 Cr. SPECT supply gaps and remediation costs compressed margins.
Jubilant Pharmova Q2 FY27 Results: Net Profit ₹31 Cr, Down 74.1% YoY
Jubilant Pharmova Ltd reported revenue from operations of ₹2,370 Cr (+20.5% YoY) and net profit of ₹31 Cr (-74.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31 Cr · -74.1% YoY
Jubilant Pharmova Business Update
Jubilant Pharmova's subsidiary Jubilant Therapeutics will present preliminary Phase 1 clinical data for JBI-802 at the 68th ASH meeting. A company event on December 14, 2026 will discuss the data.
Other debt & borrowing announcements
All →NLC India Debt & Borrowing
NLC India fixed record dates for annual interest payments on two NCD series. Payments are due January 27, 2027 and December 21, 2026.
Viviana Power Tech Debt & Borrowing: ₹0.2 Cr
Viviana Power Tech set 6 December 2026 as the record date for its 12% NCD interest. Rs.19.72 lakh interest is payable on 21 December 2026.
- Value
- ₹0.20 Cr
Aditya Birla Capital Debt & Borrowing: ₹28 Cr
Aditya Birla Capital paid yearly NCD Series B1 interest of about Rs.28.00 Crore on its due date, 21 November 2026. No delay was reported.
- Value
- ₹28.00 Cr
Union Bank of India Debt & Borrowing: ₹2,000 Cr
Union Bank of India fully redeemed its Rs.2,000 Crore Basel III Tier 1 bond via call option. Redemption on 21 November 2026 matched the original issue size.
- Value
- ₹2,000 Cr
Union Bank of India Debt & Borrowing: ₹2,174 Cr
Union Bank of India reported full redemption of bond ISIN INE692A08169 on 21 November 2026 via call option. Total amount redeemed, including principal and coupon, was ₹2,173.52 Crore.
- Value
- ₹2,174 Cr
Power Finance Corporation Debt & Borrowing: ₹10.63 Cr
PFC fully redeemed its PFC Infra 2011-12 Series 03 and 04 bonds at maturity on 21 November 2026. Total redemption amount is Rs.10.63 Crore.
- Value
- ₹10.63 Cr